Linkage Analysis of Geographic and Clinical Clusters in Pseudomonas Cepacia Infections by Multilocus Enzyme Electrophoresis and Ribotyping

Overview

Journal J Clin Microbiol

Specialty Microbiology

Date 1994 Apr 1

PMID 7517953

Citations 57

Authors

W M Johnson

S D Tyler

K R ROZEE

Affiliations

Soon will be listed here.

Abstract

Multilocus enzyme electrophoresis and ribotyping were used to characterize 83 strains of Pseudomonas cepacia, mostly isolated from cystic fibrosis (CF) patients, although a number of isolates from non-CF nosocomial infections and reference environmental strains were represented. Twenty enzyme electrophoretic types (ETs) were determined; of these, one clone (ET12) was associated with six of nine ribotypes (RTs) said to be geographically representative of the United Kingdom and all of the Ontario (Canada) isolates from CF patients. This clone was not associated with nosocomial infections or environmental strains and was never found in CF isolates from British Columbia or Nova Scotia, Canada, or a center in the eastern United States. Individual isolate EcoRI RT signatures did not cluster geographically as did the ET signatures by clonal analysis. Frequently RTs occurred in more than a single ET. Known point source focal nosocomial outbreaks were typified by single ETs and stable RTs. Dendrographic analysis of the strains grouped those strains from CF patients, nosocomial outbreaks, and environmental sources into separate ET families, and diversity analysis indicated that, with the exception of ET17, CF isolates clustered in unique and closely related ETs different from those from nosocomial and environmental sources. This study has also shown the potential of multilocus enzyme electrophoresis to monitor the intercontinental spread of P. cepacia strains in CF patients, and this may have a significant impact on plans for CF patient summer camps and design of infection control practices. Whether the intercontinental ET12 clone, which predominates in the United Kingdom and the province of Ontario, linked by summer camp acquisition, has increased virulence for CF patients remains to be established.

Citing Articles

A Polyclonal Antibody Raised against the OmpA-like Protein BCAL2645 Impairs the Bacterium Adhesion and Invasion of Human Epithelial Cells In Vitro.

Seixas A, Sousa S, Feliciano J, Gomes S, Ferreira M, Moreira L Biomedicines. 2021; 9(12).

PMID: 34944603 PMC: 8698911. DOI: 10.3390/biomedicines9121788.

Interactions Between Pathogenic and the Complement System: A Review of Potential Immune Evasion Mechanisms.

Syed I, Wooten R Front Cell Infect Microbiol. 2021; 11:701362.

PMID: 34660335 PMC: 8515183. DOI: 10.3389/fcimb.2021.701362.

Microbiology of Cystic Fibrosis Airway Disease.

Blanchard A, Waters V Semin Respir Crit Care Med. 2019; 40(6):727-736.

PMID: 31887768 PMC: 7117079. DOI: 10.1055/s-0039-1698464.

Genomic analyses of Burkholderia cenocepacia reveal multiple species with differential host-adaptation to plants and humans.

Wallner A, King E, Ngonkeu E, Moulin L, Bena G BMC Genomics. 2019; 20(1):803.

PMID: 31684866 PMC: 6829993. DOI: 10.1186/s12864-019-6186-z.

Burkholderia cepacia complex in cystic fibrosis in the post-epidemic period: multilocus sequence typing-based approach.

Fila L, Drevinek P Folia Microbiol (Praha). 2017; 62(6):509-514.

PMID: 28364392 DOI: 10.1007/s12223-017-0523-x.

References

Selander R, Musser J, Caugant D, Gilmour M, Whittam T . Population genetics of pathogenic bacteria. Microb Pathog. 1987; 3(1):1-7. DOI: 10.1016/0882-4010(87)90032-5. View

Smith D, Smith E, Gumery L, Stableforth D . Pseudomonas cepacia infection in cystic fibrosis. Lancet. 1992; 339(8787):252. DOI: 10.1016/0140-6736(92)90063-9. View

Denamur E, Picard B, GOULLET P, Bingen E, Lambert N, Elion J . Complexity of Pseudomonas aeruginosa infection in cystic fibrosis: combined results from esterase electrophoresis and rDNA restriction fragment length polymorphism analysis. Epidemiol Infect. 1991; 106(3):531-9. PMC: 2271867. DOI: 10.1017/s0950268800067595. View

Tablan O, Chorba T, Schidlow D, White J, Hardy K, Gilligan P . Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985; 107(3):382-7. DOI: 10.1016/s0022-3476(85)80511-4. View

Lewin L, Byard P, DAVIS P . Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol. 1990; 43(2):125-31. DOI: 10.1016/0895-4356(90)90175-o. View

Bingen E, Weber M, Derelle J, Brahimi N, Vidailhet M, Navarro J . Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients. J Clin Microbiol. 1993; 31(10):2589-93. PMC: 265941. DOI: 10.1128/jcm.31.10.2589-2593.1993. View

Govan J, Brown P, Maddison J, Doherty C, Nelson J, Dodd M . Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet. 1993; 342(8862):15-9. DOI: 10.1016/0140-6736(93)91881-l. View

LiPuma J, Dasen S, Nielson D, Stern R, Stull T . Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet. 1990; 336(8723):1094-6. DOI: 10.1016/0140-6736(90)92571-x. View

Martinetti G, Altwegg M . rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis. Res Microbiol. 1990; 141(9):1151-62. DOI: 10.1016/0923-2508(90)90088-8. View

10.

Rabkin C, Jarvis W, Anderson R, GOVAN J, Klinger J, Lipuma J . Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis. 1989; 11(4):600-7. DOI: 10.1093/clinids/11.4.600. View

11.

LiPuma J, Fisher M, Dasen S, Mortensen J, Stull T . Ribotype stability of serial pulmonary isolates of Pseudomonas cepacia. J Infect Dis. 1991; 164(1):133-6. DOI: 10.1093/infdis/164.1.133. View

12.

Simmonds E, Conway S, Ghoneim A, Ross H, Littlewood J . Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child. 1990; 65(8):874-7. PMC: 1792469. DOI: 10.1136/adc.65.8.874. View

13.

Smith D, Gumery L, Smith E, Stableforth D, Kaufmann M, Pitt T . Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol. 1993; 31(11):3017-22. PMC: 266193. DOI: 10.1128/jcm.31.11.3017-3022.1993. View

14.

Hedrick P, Thomson G . A two-locus neutrality test: applications to humans, E. coli and lodgepole pine. Genetics. 1986; 112(1):135-56. PMC: 1202687. DOI: 10.1093/genetics/112.1.135. View

15.

Mukwaya G, Welch D . Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol. 1989; 27(12):2640-6. PMC: 267100. DOI: 10.1128/jcm.27.12.2640-2646.1989. View

16.

Eerola E, Lehtonen O . Optimal data processing procedure for automatic bacterial identification by gas-liquid chromatography of cellular fatty acids. J Clin Microbiol. 1988; 26(9):1745-53. PMC: 266709. DOI: 10.1128/jcm.26.9.1745-1753.1988. View

17.

Burdge D, Nakielna E, Noble M . Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol. 1993; 14(3):127-30. DOI: 10.1086/646697. View

18.

Carson L, Anderson R, Panlilio A, Miller J . Isoenzyme analysis of Pseudomonas cepacia as an epidemiologic tool. Am J Med. 1991; 91(3B):252S-255S. DOI: 10.1016/0002-9343(91)90377-a. View

19.

Selander R, Caugant D, Ochman H, Musser J, Gilmour M, Whittam T . Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics. Appl Environ Microbiol. 1986; 51(5):873-84. PMC: 238981. DOI: 10.1128/aem.51.5.873-884.1986. View

20.

Isles A, MacLusky I, Corey M, Gold R, Prober C, Fleming P . Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr. 1984; 104(2):206-10. DOI: 10.1016/s0022-3476(84)80993-2. View